Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Candida albicans cell wall is a dynamic, multilayered structural organelle essential for cell survival, shape, and virulence. It comprises approximately 80-90% carbohydrate and 6-25% protein by weight. The cell wall has a bilayered architecture with an inner skeletal layer and an outer layer that determines surface properties. The inner skeletal layer consists primarily of β-1,3-glucan (47-60% of cell wall) forming a fibrillar network that is covalently cross-linked with β-1,6-glucan and chitin (0.6-9% of cell wall). These structural polysaccharides provide mechanical strength and maintain cell shape. The outer layer is enriched with mannoproteins (30-40% of cell wall), which are predominantly glycosylphosphatidylinositol-modified proteins covalently linked to the skeletal polysaccharides via β-1,6-glucan bridges. The cell wall composition and organization result from a dynamic equilibrium between synthesis and remodeling of constituent polysaccharides, adapting to environmental stresses and morphological transitions. β-1,6-glucan plays a crucial interconnecting role, linking β-1,3-glucan, chitin, and mannoproteins into an integrated structure. The cell wall is not merely a protective barrier but actively participates in adhesion, immune recognition, and pathogenicity, making it a primary target for antifungal therapeutic interventions.
Inhibition of β-1,3-glucan synthase (disrupts cell wall integrity); Inhibition of chitin synthesis (compromises structural skeleton); Disruption of glucan-chitin cross-linking; Interference with cell wall polysaccharide biosynthesis
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Candida albicans cell wall.